Drug Profile
Research programme: erectile dysfunction gene therapy - University of Pittsburgh
Alternative Names: Post-radical prostatectomy erectile dysfunction gene therapyLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator University of Pittsburgh Medical Center
- Class Gene therapies
- Mechanism of Action Nerve growth factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Erectile dysfunction
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Erectile-dysfunction in USA (Injection)
- 01 May 2007 This programme is still in active development
- 05 May 2003 Preclinical trials in Erectile dysfunction in USA (Injection)